Safety of zoster vaccine in adults from a large managed-care cohort: A Vaccine Safety Datalink study

Journal of Internal Medicine

Volumn 271, Issue 5, 2012, Pages 510-520

  Tseng, H F ^a   Liu, A ^a   Sy, L ^a   Marcy, S M ^a   Fireman, B ^a   Weintraub, E ^b   Baggs, J ^b   Weinmann, S ^a   Baxter, R ^a   Nordin, J ^c   Daley, M F ^a   Jackson, L ^d   Jacobsen, S J ^a  

^a KAISER PERMANENTE   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c HEALTHPARTNERS RESEARCH FOUNDATION   (United States)

^d CENTER FOR HEALTH STUDIES   (United States)

Author keywords

Adult vaccination; Case centered method; Herpes zoster vaccine; Self controlled case series; Varicella zoster virus

Indexed keywords

VARICELLA ZOSTER VACCINE;

ADULT; AGED; ALLERGIC REACTION; ARTICLE; BELL PALSY; BRAIN DISEASE; CARDIOVASCULAR DISEASE; CEREBROVASCULAR DISEASE; COHORT ANALYSIS; DRUG SAFETY; DRUG TOLERABILITY; ENCEPHALITIS; FEMALE; HERPES ZOSTER; HERPES ZOSTER OTICUS; HUMAN; INFECTION PREVENTION; INTERNATIONAL CLASSIFICATION OF DISEASES; MAJOR CLINICAL STUDY; MALE; MANAGED CARE; MENINGITIS; PRIORITY JOURNAL; RISK ASSESSMENT;

ADVERSE DRUG REACTION REPORTING SYSTEMS; AGED; AGED, 80 AND OVER; CARDIOVASCULAR DISEASES; COHORT STUDIES; FEMALE; HERPES ZOSTER; HERPES ZOSTER VACCINE; HUMANS; HYPERSENSITIVITY; MALE; MIDDLE AGED; NERVOUS SYSTEM DISEASES; POPULATION SURVEILLANCE; RISK ASSESSMENT; TIME FACTORS; UNITED STATES;

EID: 84860232852     PISSN: 09546820     EISSN: 13652796     Source Type: Journal    
DOI: 10.1111/j.1365-2796.2011.02474.x     Document Type: Article

References (24)

1. Donahue JG, Belongia EA. The looming rash of herpes zoster and the challenge of adult immunization. Ann Intern Med 2010; 152: 609-11.
2. Harpaz R, Ortega-Sanchez IR, Seward JF. Prevention of herpes zoster: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2008; 57: 1-30.
3. Oxman MN, Levin MJ, Johnson GR et al. A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med 2005; 352: 2271-84.
4. Simberkoff MS, Arbeit RD, Johnson GR et al. Safety of herpes zoster vaccine in the shingles prevention study: a randomized trial. Ann Intern Med 2010; 152: 545-54.
5. Chen RT, Glasser JW, Rhodes PH et al. Vaccine Safety Datalink project: a new tool for improving vaccine safety monitoring in the United States. The Vaccine Safety Datalink Team. Pediatrics 1997; 99: 765-73.
6. Singleton JA, Lloyd JC, Mootrey GT, Salive ME, Chen RT. An overview of the vaccine adverse event reporting system (VAERS) as a surveillance system. VAERS Working Group. Vaccine 1999; 17: 2908-17.
7. Stjernquist-Desatnik A, Skoog E, Aurelius E. Detection of herpes simplex and varicella-zoster viruses in patients with Bell's palsy by the polymerase chain reaction technique. Ann Otol Rhinol Laryngol 2006; 115: 306-11.
8. Pitkaranta A, Piiparinen H, Mannonen L, Vesaluoma M, Vaheri A. Detection of human herpesvirus 6 and varicella-zoster virus in tear fluid of patients with Bell's palsy by PCR. J Clin Microbiol 2000; 38: 2753-5.
9. Gilden DH, Kleinschmidt-DeMasters BK, LaGuardia JJ, Mahalingam R, Cohrs RJ. Neurologic complications of the reactivation of varicella-zoster virus. N Engl J Med 2000; 342: 635-45.
10. Gilden DH, Mahalingam R, Cohrs RJ, Kleinschmidt-DeMasters BK, Forghani B. The protean manifestations of varicella-zoster virus vasculopathy. J Neurovirol 2002; 8(Suppl 2): 75-9.
11. Kleinschmidt-DeMasters BK, Gilden DH. Varicella-Zoster virus infections of the nervous system: clinical and pathologic correlates. Arch Pathol Lab Med 2001; 125: 770-80.
12. Donahue JG, Kieke BA, Yih WK et al. Varicella vaccination and ischemic stroke in children: is there an association? Pediatrics 2009; 123: e228-34.
13. Jackson LA, Yu O, Nelson J et al. Risk of medically attended local reactions following diphtheria toxoid containing vaccines in adolescents and young adults: a Vaccine Safety Datalink study. Vaccine 2009; 27: 4912-6.
14. Ray P, Hayward J, Michelson D et al. Encephalopathy after whole-cell pertussis or measles vaccination: lack of evidence for a causal association in a retrospective case-control study. Pediatr Infect Dis J 2006; 25: 768-73.
15. Fireman B, Lee J, Lewis N, Bembom O, van der Laan M, Baxter R. Influenza vaccination and mortality: differentiating vaccine effects from bias. Am J Epidemiol 2009; 170: 650-6.
16. Klein NP, Fireman B, Yih WK et al. Measles-mumps-rubella-varicella combination vaccine and the risk of febrile seizures. Pediatrics 2010; 126: e1-8.
17. Baxter R, Ray GT, Fireman BH. Effect of influenza vaccination on hospitalizations in persons aged 50years and older. Vaccine 2010; 28: 7267-72.
18. Farrington CP. Relative incidence estimation from case series for vaccine safety evaluation. Biometrics 1995; 51: 228-35.
19. Musonda P, Farrington CP, Whitaker HJ. Sample sizes for self-controlled case series studies. Stat Med 2006; 25: 2618-31.
20. Levin MJ, Oxman MN, Zhang JH et al. Varicella-zoster virus-specific immune responses in elderly recipients of a herpes zoster vaccine. J Infect Dis 2008; 197: 825-35.
21. Centers for Disease Control and Prevention. Smallpox vaccine adverse events among civilians - United States, March 4-10, 2003. MMWR Morb Mortal Wkly Rep 2003; 52: 201-3.
22. Salzman MB, Sharrar RG, Steinberg S, LaRussa P. Transmission of varicella-vaccine virus from a healthy 12-month-old child to his pregnant mother. J Pediatr 1997; 131: 151-4.
23. Baxter R, Lee J, Fireman B. Evidence of bias in studies of influenza vaccine effectiveness in elderly patients. J Infect Dis 2010; 201: 186-9.
24. Lu PJ, Euler GL, Harpaz R. Herpes zoster vaccination among adults aged 60years and older, in the U.S., 2008. Am J Prev Med 2011; 40: e1-6.